Form 4 for OSCR Oscar Health, Inc.
Accepted 2025-04-07 00:00:00 ET · period of report 2025-04-03 · accession 0001562180-25-003037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-07 | 2025-04-03 | OSCR | Bertolini Mark T | CEO, Dir | M - OptEx | $0.00 | +955.6K | 2.87M | +50% | $0 |
| D | 2025-04-07 | 2025-04-03 | OSCR | Bertolini Mark T | CEO, Dir | M - OptEx | $0.00 | -955.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-04-03 | M | A | 955,556 | $0.00 | 2,866,666 | D | — | — | (F1) Represents shares issued upon the vesting of restricted stock units previously reported in Table II. (F2) Amount reflects that 955,555 shares to be issued upon the vesting of restricted stock units and that were previously reported on Table II are now reported on Table I. |
| 2 | Derivative | Restricted Stock Units | 2025-04-03 | M | D | 955,556 | $0.00 | 0 | D | — · — to — | 955,556 Class A Common Stock | (F2) Amount reflects that 955,555 shares to be issued upon the vesting of restricted stock units and that were previously reported on Table II are now reported on Table I. (F3) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F4) The restricted stock units vest in three equal annual installments beginning on April 3, 2024, subject to the Reporting Person's continued employment or service as the Chief Executive Officer or as a member of the Board of Directors through the applicable vesting date. |